The whale feed
Who just crossed 5%?
When anyone — family offices, activist funds, sovereign wealth, famous CEOs buying into other companies — crosses a 3–5% voting- rights threshold in an EU or UK listed company, they must disclose it within 2–4 trading days. A different signal from Article 19 PDMR filings — conviction across the table, not inside one.
Affiliate links — we may earn a referral fee if you sign up.
Matching filings
Showing 7 most recent| Filed | Filer | Company | Move | New % | Source |
|---|---|---|---|---|---|
| 2026-02-03 3mo ago | 🇨🇭n/a n/a | BioVersys AG | ↓ crossed below | 3.00% | regulator → |
| 2025-11-19 6mo ago | 🇨🇭ViaValor AG | BioVersys AG | ↑ crossed above | 3.43% | regulator → |
| 2025-11-19 6mo ago | 🇨🇭Barrus AG | BioVersys AG | ↓ crossed below | 3.00% | regulator → |
| 2025-09-24 7mo ago | 🇨🇭UBS Fund Management (Switzerland) AG | BioVersys AG | ↑ crossed above | 5.69% | regulator → |
| 2025-08-13 9mo ago | 🇨🇭Marc Jaquet | BioVersys AG | ↑ crossed above | 3.14% | regulator → |
| 2025-08-08 9mo ago | 🇨🇭Jaquet Marc | BioVersys AG | ↓ crossed below | 3.00% | regulator → |
| 2025-08-08 9mo ago | 🇨🇭Glaxo Group Limited | BioVersys AG | ↑ crossed above | 4.35% | regulator → |
Why this signal matters
A CEO buying €1m of their own stock is confidence. A family office quietly accumulating 5% of a small listed industrial is conviction across the table — and often a leading indicator of an activist campaign, a take-private bid, a sovereign wealth allocation, or a cornerstone investment. Academic literature (Brav, Jiang, Kim 2010 on activism; Bebchuk et al 2013) consistently finds substantial outperformance in the months following 13D / equivalent filings in the US. Europe's Transparency Directive is the European equivalent.